These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15126331)

  • 41. The Fanconi anemia/BRCA pathway is involved in DNA interstrand cross-link repair of adriamycin-resistant leukemia cells.
    Yao C; Du W; Chen H; Xiao S; Huang L; Chen F
    Leuk Lymphoma; 2015 Mar; 56(3):755-62. PubMed ID: 24996439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IGSF4 promoter methylation and expression silencing in human cervical cancer.
    Li J; Zhang Z; Bidder M; Funk MC; Nguyen L; Goodfellow PJ; Rader JS
    Gynecol Oncol; 2005 Jan; 96(1):150-8. PubMed ID: 15589594
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Defects in the Fanconi Anemia Pathway and Chromatid Cohesion in Head and Neck Cancer.
    Stoepker C; Ameziane N; van der Lelij P; Kooi IE; Oostra AB; Rooimans MA; van Mil SE; Brink A; Dietrich R; Balk JA; Ylstra B; Joenje H; Feller SM; Brakenhoff RH
    Cancer Res; 2015 Sep; 75(17):3543-53. PubMed ID: 26122845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phenotypic variability in patients with Fanconi anemia and biallelic FANCF mutations.
    Tryon R; Zierhut H; MacMillan ML; Wagner JE
    Am J Med Genet A; 2017 Jan; 173(1):260-263. PubMed ID: 27714961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
    Chandrasekharappa SC; Chinn SB; Donovan FX; Chowdhury NI; Kamat A; Adeyemo AA; Thomas JW; Vemulapalli M; Hussey CS; Reid HH; Mullikin JC; Wei Q; Sturgis EM
    Cancer; 2017 Oct; 123(20):3943-3954. PubMed ID: 28678401
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM.
    de Winter JP; Rooimans MA; van Der Weel L; van Berkel CG; Alon N; Bosnoyan-Collins L; de Groot J; Zhi Y; Waisfisz Q; Pronk JC; Arwert F; Mathew CG; Scheper RJ; Hoatlin ME; Buchwald M; Joenje H
    Nat Genet; 2000 Jan; 24(1):15-6. PubMed ID: 10615118
    [No Abstract]   [Full Text] [Related]  

  • 48. Sodium-coupled monocarboxylate transporter is a target of epigenetic repression in cervical cancer.
    Hernández-Juárez J; Vargas-Sierra O; Herrera LA; Cantú De León D; Fernández-Retana J; Pérez-Plasencia C; López-Camarillo C; Gariglio P; Díaz-Chávez J
    Int J Oncol; 2019 May; 54(5):1613-1624. PubMed ID: 30896789
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer.
    Lyakhovich A; Surralles J
    Cancer Lett; 2006 Jan; 232(1):99-106. PubMed ID: 16246487
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix.
    Dong SM; Kim HS; Rha SH; Sidransky D
    Clin Cancer Res; 2001 Jul; 7(7):1982-6. PubMed ID: 11448914
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identifying and exploiting defects in the Fanconi anemia/BRCA pathway in oncology.
    Stecklein SR; Jensen RA
    Transl Res; 2012 Sep; 160(3):178-97. PubMed ID: 22683426
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment.
    Martinez A; Hinz JM; Gómez L; Molina B; Acuña H; Jones IM; Frias S; Coleman MA
    Mutat Res; 2008 Oct; 656(1-2):1-7. PubMed ID: 18647660
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of a FANCE Splice Isoform in Regard to DNA Repair.
    Bouffard F; Plourde K; Bélanger S; Ouellette G; Labrie Y; Durocher F
    J Mol Biol; 2015 Sep; 427(19):3056-73. PubMed ID: 26277624
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involvement of Fanconi anemia genes FANCD2 and FANCF in the molecular basis of drug resistance in leukemia.
    Yao C; Du W; Chen H; Xiao S; Huang L; Chen FP
    Mol Med Rep; 2015 Jun; 11(6):4605-10. PubMed ID: 25647473
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Breast cancer and Fanconi anemia: what are the connections?
    Zdzienicka MZ; Arwert F
    Trends Mol Med; 2002 Oct; 8(10):458-60. PubMed ID: 12383764
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aberrant promoter methylation and silencing of RASSF2A gene in cervical cancer.
    Zhang X; Ma Y; Wu Y; Lin L; Ma X; Zhang Y
    J Obstet Gynaecol Res; 2014 May; 40(5):1375-81. PubMed ID: 24605823
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Progress of research on protein composition and gene therapy of Fanconi anaemia - review].
    Li ZY; Zou YF; Deng YB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr; 12(2):231-5. PubMed ID: 15157341
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Boolean network model of the FA/BRCA pathway.
    Rodríguez A; Sosa D; Torres L; Molina B; Frías S; Mendoza L
    Bioinformatics; 2012 Mar; 28(6):858-66. PubMed ID: 22267503
    [TBL] [Abstract][Full Text] [Related]  

  • 59. RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cells.
    Zhao L; Li N; Yu JK; Tang HT; Li YL; He M; Yu ZJ; Bai XF; Zheng ZH; Wang EH; Wei MJ
    Braz J Med Biol Res; 2014 Jan; 47(1):24-34. PubMed ID: 24345874
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arsenic exposure disrupts the normal function of the FA/BRCA repair pathway.
    Peremartí J; Ramos F; Marcos R; Hernández A
    Toxicol Sci; 2014 Nov; 142(1):93-104. PubMed ID: 25092648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.